Immune System News and Research

RSS

Researchers discover how byproducts from bacteria prevalent in gum disease incite growth of deadly tumors

Researchers from Case Western Reserve University have discovered how byproducts in the form of small fatty acids from two bacteria prevalent in gum disease incite the growth of deadly Kaposi's sarcoma-related (KS) lesions and tumors in the mouth.

26 Feb 2014

Johns Hopkins researchers use tiny particles to train immune systems of mice to fight melanoma

Using tiny particles designed to target cancer-fighting immune cells, Johns Hopkins researchers have trained the immune systems of mice to fight melanoma, a deadly skin cancer. The experiments, described tk on the website of ACS Nano, represent a significant step toward using nanoparticles and magnetism to treat a variety of conditions, the researchers say.

26 Feb 2014

Healthy Directions launches Krill Omega Defense

Healthy Directions, LLC, today announced the launch of Krill Omega Defense™, a unique krill supplement formulated by Julian Whitaker, MD, that supports and maintains the health of the body's key biological functions and systems—from the heart, brain, and nerves to the eyes and bones.

25 Feb 2014

Scientists show promising results for new treatment approach in follicular lymphoma

A study led by Manchester scientists has shown promising results for a new treatment approach in follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin's lymphoma- a blood cancer - that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage.

25 Feb 2014

Tel Aviv University scientists target drug-resistant ovarian tumors with nanotechnology

Ovarian cancer accounts for more deaths of American women than any other cancer of the female reproductive system. According to the American Cancer Society, one in 72 American women will be diagnosed with ovarian cancer, and one in 100 will ultimately die of the condition.

24 Feb 2014

New system delivers anti-inflammatory drugs to immune cells gone out of control

Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts. Their findings were published online Feb. 23 in Nature Nanotechnology.

24 Feb 2014

Self Regional Healthcare, Clemson University expand partnership to accelerate rate of innovation in genetic medicine

A new partnership will establish formal collaboration among genetic researchers and Clemson University faculty at the Greenwood Genetic Center and Self Regional Healthcare, expanding an already successful working relationship.

24 Feb 2014

Researchers identify novel strategies to develop more efficient vaccines against encapsulated bacteria

Researchers have discovered the presence of a novel subtype of innate lymphoid cells in human spleen essential for the production of antibodies. This discovery, published in the prestigious journal Nature Immunology, clears the path to the identification of novel strategies to develop more efficient vaccines against encapsulated bacteria, considered highly virulent.

24 Feb 2014

Scientists develop stem cell based method for restoring strength to damaged skeletal muscles in elderly

A study co-published in Nature Medicine this week by University of Toronto researcher Penney Gilbert has determined a stem cell based method for restoring strength to damaged skeletal muscles of the elderly.

24 Feb 2014

Scientists discover how viral DNA of HBV can be degraded in cell nucleus

Scientists from the Helmholtz Zentrum München and the Technische Universität München have discovered how the viral DNA of the hepatitis B virus (HBV) can be degraded in the cell nucleus of liver cells, consequently allowing the virus to be eliminated.

24 Feb 2014

People suffering from schizophrenia at greater risk of developing autoimmune diseases

Researchers have long known that people with autoimmune diseases, such as hepatitis, type 1 diabetes, multiple sclerosis and psoriasis, are at greater risk of developing schizophrenia.

24 Feb 2014

Researchers discover that immune cells control blood stem cells in bone marrow

Researchers in Bern have discovered that, during a viral infection, immune cells control the blood stem cells in the bone marrow and therefore also the body's own defences. The findings could allow for new forms of therapy, such as for bone marrow diseases like leukaemia.

24 Feb 2014

Cell therapy: A powerful treatment for cancer patients

Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to date of patients with advanced leukemia found that 88 percent achieved complete remissions after being treated with genetically modified versions of their own immune cells.

24 Feb 2014

New research finds direct connection between acupuncture and processes that alleviate sepsis

When acupuncture first became popular in the western hemisphere it had its doubters. It still does. But over time, through detailed observation, scientists have produced real evidence that ancient Chinese practitioners of the medical arts were onto something.

23 Feb 2014

Research sheds light on pathological mechanisms that trigger psoriasis lesions

Streptococcal antigens (Streptococcus pyogenes) might be directly involved in the pathological mechanisms that result in the appearance of psoriasis lesions.

21 Feb 2014

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

Most people have heard of severe allergies, or anaphylaxis, to food, insect stings, drugs and other common substances, but sometimes no cause at all can be found for a person’s reaction – a condition called Idiopathic anaphylaxis.

21 Feb 2014

XenoPort reports net loss of $19.1 million for fourth quarter 2013

XenoPort, Inc. announced today its financial results for the fourth quarter and year ended December 31, 2013. Revenues for the fourth quarter were $2.9 million, compared to $0.5 million for the same period in 2012. Net loss for the fourth quarter was $19.1 million compared to net income of $3.0 million that resulted from a non-cash gain from XenoPort's litigation settlement with Glaxo Group Limited in the fourth quarter of 2012. At December 31, 2013, XenoPort had cash and cash equivalents and short-term investments of $58.7 million.

20 Feb 2014

Immune System News and Research

Researchers discover how byproducts from bacteria prevalent in gum disease incite growth of deadly tumors

Johns Hopkins researchers use tiny particles to train immune systems of mice to fight melanoma

Healthy Directions launches Krill Omega Defense

Scientists show promising results for new treatment approach in follicular lymphoma

Tel Aviv University scientists target drug-resistant ovarian tumors with nanotechnology

New system delivers anti-inflammatory drugs to immune cells gone out of control

Self Regional Healthcare, Clemson University expand partnership to accelerate rate of innovation in genetic medicine

Researchers identify novel strategies to develop more efficient vaccines against encapsulated bacteria

Scientists develop stem cell based method for restoring strength to damaged skeletal muscles in elderly

Scientists discover how viral DNA of HBV can be degraded in cell nucleus

People suffering from schizophrenia at greater risk of developing autoimmune diseases

Researchers discover that immune cells control blood stem cells in bone marrow

Cell therapy: A powerful treatment for cancer patients

New research finds direct connection between acupuncture and processes that alleviate sepsis

Research sheds light on pathological mechanisms that trigger psoriasis lesions

Anaphylaxis Campaign provides updated information on Idiopathic anaphylaxis

XenoPort reports net loss of $19.1 million for fourth quarter 2013

Professor receives $17M NIH grant to support IMPAACT Network

Vaccine-based clinical trial to improve survival outcomes of kidney cancer patients

CardioCell announces new clinical trials using allogeneic stem-cell therapy to treat subjects with AMI

Immunology eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News